Your search returned 3 results.

Results
	1.	Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer. [electronic resource] by Pivot, Xavier B Li, Rubi K Thomas, Eva S Chung, Hyun-Cheol Fein, Luis E Chan, Valorie F Jassem, Jacek de Mendoza, Fernando Hurtado Mukhopadyay, Pralay Roché, Henri H Producer: 20100127 In: European journal of cancer (Oxford, England : 1990) vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes. [electronic resource] by Hortobagyi, Gabriel N Gomez, Henry L Li, Rubi K Chung, Hyun-Cheol Fein, Luis E Chan, Valorie F Jassem, Jacek Lerzo, Guillermo L Pivot, Xavier B Hurtado de Mendoza, Fernando Xu, Binghe Vahdat, Linda T Peck, Ronald A Mukhopadhyay, Pralay Roché, Henri H Producer: 20100927 In: Breast cancer research and treatment vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. [electronic resource] by Thomas, Eva S Gomez, Henry L Li, Rubi K Chung, Hyun-Cheol Fein, Luis E Chan, Valorie F Jassem, Jacek Pivot, Xavier B Klimovsky, Judith V de Mendoza, Fernando Hurtado Xu, Binghe Campone, Mario Lerzo, Guillermo L Peck, Ronald A Mukhopadhyay, Pralay Vahdat, Linda T Roché, Henri H Producer: 20071206 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)